Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement

Celularity regained compliance with Nasdaq Listing Rule 5250(c)(1) on timely periodic filings, after filing its overdue 10-Q for the period ended June 30, 2026 on October 20. All three previously disclosed Nasdaq deficiency matters are now closed, including the minimum bid price and market value requirements resolved on September 11.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.